针对协同功效的cuproptosis-免疫疗法的工程抗癌纳米药物
Jiaxin Li1, Xinlong Pang2, Zhongwei Xin3,2
1Tumor Research and Therapy Center, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Shandong, Jinan, 250022, China.
Materials today. Bio
|August 12, 2025
概括
铜亡是一种新型的细胞死亡途径,涉及铜,可以增强癌症免疫疗法. 通过准这一过程,研究人员旨在克服瘤免疫逃避并提高治疗效率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞死亡研究 细胞死亡研究
背景情况:
- 癌症免疫疗法面临诸如"冷瘤",免疫抑制瘤微环境和癌细胞免疫逃避等挑战.
- 在癌症治疗期间选择性增强免疫反应对于改善治疗结果至关重要.
研究的目的:
- 探索cuproptosis作为一种新的策略来增强抗瘤免疫力.
- 研究cuproptosis在克服瘤免疫逃避和提高免疫疗法疗效方面的潜力.
主要方法:
- 研究了cuproptosis,这是一个受调节的细胞死亡,其特征是铜离子积累和代谢功能障碍.
- 研究了cuproptosis和瘤微环境之间的联系.
- 探索了cuproptosis可以激活瘤内的免疫反应的机制.
主要成果:
- 质亡与瘤微环境有着固有的联系.
- 针对性的cuproptosis激活可以选择性地诱导瘤区域的免疫反应.
- 质亡有潜力抵消瘤介导的免疫逃避.
结论:
- cuproptosis是一个有前途的方法来提高癌症免疫治疗的疗效.
- 将 cuproptosis 诱导策略与免疫疗法结合起来,为癌症治疗提供了一个新的治疗方向.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.2K
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
